OBJECTIVE -The goal of this study was to estimate the excess hospitalizations, hospital days, and inpatient costs attributable to diabetes in Andalusia, Spain (37 hospitals, 7, 236,459 inhabitants), during 1999 compared with those without diabetes.
D
iabetes is one of the most important public health problems worldwide. An estimated 300 million individuals will have the disease by the year 2025 (1) . Prevalence studies in Spain corroborate this trend (2) . Studies of the costs associated with diabetes show that the direct burden resulting from its treatment is very high in relation to its prevalence (3) (4) (5) (6) (7) (8) .
From 30 to 50% of expenses arising from diabetes correspond to indirect costs, with the rest corresponding to the direct cost of health care (3, 6, 9) . Studies in Spain, Europe, and the U.S. generally agree that most direct costs are due to inpatient care of the associated chronic complications of diabetes (3) (4) (5) (6) (7) (8) (9) . Care of individuals with diabetes generates a disproportionate use of hospital resources relative to the prevalence of diabetes (10 -12) . The greatest impact on hospital stay and expense is from hospitalizations for chronic complications, especially cardiovascular complications (8, 12) .
Data published in Spain on hospital costs generally came from small-or medium-sized hospitals (10 -12) , or they were calculated from theoretical estimates based on prevalence studies (7) or from smaller samples of patients from the primary care setting only (4, 8) . Very few European studies, and none in Spain, have focused their hospitalization data of individuals with diabetes to estimate the excess cost. Moreover, those that have have carried out population-based analyses using low populational prevalence data for diabetes (13) . In this study, we estimated the excess costs attributable to hospitalization of individuals with diabetes using a population-based analysis in Andalusia, a region in Southern Spain with Ͼ7 million inhabitants, using up-to-date prevalence data for diabetes.
RESEARCH DESIGN AND
METHODS -Andalusia has its own health care service under the Andalusian Consejería de Salud. The population of Andalusia is 7,236,459 inhabitants, with health care provided to Ͼ98% of these individuals (14). We analyzed all admissions during 1999 to all the hospitals under the jurisdiction of the Consejería de Salud (5 first-level regional centers, 9 second level, and 18 local). The only admissions excluded were those of newborns. The study population was stratified by age into the following groups: Ͻ15 years, 15-44 years, 45-75 years, and Ͼ75 years.
The diagnoses and procedures of all hospital discharges were coded in accordance with the ICD-9-CM. All hospital discharges that included diagnostic category 250 as the main or secondary medical diagnosis (in any of its 10 sections) were considered to refer to individuals with diabetes. The remaining hospital discharges not classified under diagnostic category 250 were considered to relate to treatment of individuals without diabetes.
All hospitalization episodes were classified according to the diagnosticrelated group (DRG) derived from the corresponding ICD-9-CM codes and translated by the All Patients DRGs software (vol. 12, 1996) . Each diabetic subject was further classified into the following mutually exclusive groups based upon reported DRG (Table 1) : 1) acute complications, 2) chronic complications of diabetes, and 3) other comorbid conditions (all remaining hospitalizations). The specific conditions considered to be chronic complications of diabetes and the associated DRGs were based on those published by the American Diabetes Association and in other relevant peerreviewed literature (6, 10, 15) (Table 1) .
Rates of hospitalization for individuals with and without diabetes were calculated for each age-group by dividing the number of hospitalizations by the respective population at risk. The relative risk of hospitalization was estimated by dividing the rate of hospitalization of individuals with diabetes by the rate of hospitalization of individuals without diabetes. We used the prevalence data of diabetes in the general population published for the different populations in Spain (2, 16) . The following prevalence data were used: Ͻ15 years of age (0.1% of the general population), 15-44 years (0.85% of the general population), 45-75 years (7% of the general population), and Ͼ75 years (17% of the general population).
Estimation of costs
A specific financial control system has been established by the Consejería de Salud based on the DRG of the patient. An estimate of costs was applied to every inpatient admission by assigning a cost weight based on the DRG related to each admission. In 1999, the cost of one DRG point was €1,357. The sum of all such cost weights was calculated for each agegroup and disease type according to the DRG for both diabetes-and nondiabetes-related admissions. The results are expressed in euros.
Determination of excess hospitalization, stays, and costs The excess numbers of admissions, hospital days, and costs generated by individuals with diabetes were calculated by estimating the expected value, based on admission indexes, the mean stay, and the hospital costs in individuals without diabetes for each group studied. These were then subtracted from the observed findings for individuals with diabetes (13) . These calculations were made for the total number of admissions and for each of the different groups studied classified according to the DRG and age. Table 2 summarizes the overall and age-grouped results of the de- Of the total cost generated by hospitalization of individuals with diabetes (€132,509,217), 58.3% (€77,206,772) was directly attributable to the presence of diabetes (excess costs). Figure 1 specifies the percentages attributable to the excess costs in relation to the total cost generated by hospitalization of individuals with diabetes. Figure 2 shows the percentage contribution by age-group to the excess costs generated by hospitalization of individuals with diabetes. Table 3 details, for the total group and for each of the age-groups studied, the distribution of admissions, stays, and costs of the individuals with diabetes as well as the expected and the excess costs for each of the diagnostic subgroups studied. CONCLUSIONS -This study shows that individuals with diabetes have a high risk of hospital admission compared with individuals without diabetes. There was a notable increase in all age-groups in stays and a disproportionate cost associated with the diagnosis. Almost 60% of all hospital costs for hospitalization of people with diabetes were excess costs, either due to chronic or acute diseases related with complications, especially those related with the cardiovascular system, or to the increased expense associated with admission for other comorbid diseases not related with diabetes. In absolute terms, it was the age-group of 45-to 75-year-old individuals who contributed most (75%) to the excess costs (Fig. 2) .
RESULTS -
The rates of hospitalization for individuals with diabetes were clearly above those of individuals without diabetes in all age-groups; this is in agreement with other studies (6, 10, 15) . The reasons for the excess admissions (and subsequent costs) in the various age-groups were well differentiated (Table 3 ). In individuals Ͻ45 years of age, this was mainly due to hospitalizations for decompensation of their diabetes. In the other two agegroups (Ͼ45 years), cardiovascular complications were the most important diabetes-related factors determining increased costs.
In absolute terms, the main factor contributing to the excess costs generated by diabetes was related to admissions for cardiovascular complications (almost 50% of the estimated excess). This occurred in all age-groups, although it was especially marked in individuals from 45-75 years of age, the data being similar to those reported by us and others (4, 6, 12, 13, 17) . The fact that our findings are similar to data from other countries, both European and American, with different health care systems reinforces the validity of the data and emphasizes the universal role of diabetes in increasing health care costs. Two factors explain this. First, the risk of admission due to cardiovascular disease in individuals with dia- 
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betes is clearly greater in all age-groups studied; our data are similar to or even higher than those of others (13, 17, 18) . Second, admissions of individuals with diabetes due to cardiovascular disease are more complex and prolonged than admissions of individuals without diabetes (from 1 to 3.4 days longer, depending on the age-group), thereby generating greater consumption of resources. Patients who have macrovascular complications cause a notable increase (at least twofold) in the direct annual costs resulting from their care, with greater increases among the younger patients (4, 19, 20) .
Individuals with diabetes who are Ͼ50 years old and who also have the metabolic syndrome, i.e., almost 90% of this group, are those who most often have cardiovascular disease, whereas this disease is hardly present in individuals with diabetes but without the metabolic syndrome (21) . In our study, it was not possible to determine the main cause of the increase in admissions for cardiovascular disease or its associated costs (whether they were due to diabetes itself or to the associated disease). Nevertheless, it seems clear that reducing the costs associated with diabetes requires aggressive control of the other components of the metabolic syndrome (obesity, blood pressure, or dyslipidemia) as well as intensifying the treatment of diabetes. This should result in notable long-term savings in both monetary terms and possibly also in terms of improved quality of life, although it probably means greater short-term expenses (5, 8, 22) . A more aggressive treatment of diabetes in hospitalized patients (especially those admitted for cardiovascular disease) with the aim of achieving optimum metabolic control is also effective at reducing morbidity and mortality and, consequently, the associated expenses (23) .
Patients with diabetes have a clear increase in the number of hospitalizations, the number of hospital days, and the costs associated with admission for comorbid diseases not related with diabetes. This had important economic repercussions in all the age-groups, as it accounted for 43% of the excess costs. The presence of diabetes may increase the incidence and severity of other diseases, leading to hospitalization, a longer mean stay, and more hospital complications. The increase in the number of visits to health care centers by individuals with diabetes also results in more admissions. For certain diseases, therefore, the presence of diabetes tends to increase the likelihood of hospital admission or of receiving more aggressive therapy (10, 15) .
Our study, however, is not without limitations. First, our estimation of costs largely depended on prevalence figures for diabetes. Nevertheless, we decided to use age values similar to other recent studies in our area (2, 16) . These figures are much higher than those used by others (7, 13) but are probably nearer the actual figures. Lower figures would have resulted in possibly even higher figures for excess costs. Second, the system of cost assignment was based on DRGs that were not designed for individuals with diabetes (who have longer mean stays than individuals without diabetes) and which simplify primary and secondary diagnoses (with the corresponding loss of information in older individuals with diabetes, who usually have more comorbid diseases). Third, it has been shown, both in our area (24) and in other countries (25) , that undercoding of hospital diabetes can be very high (from 20 to 61% of all individuals with diabetes), which would result in underestimation of the costs (24,26).
In conclusion, our study demonstrated that almost 60% of costs generated by hospitalization of individuals with diabetes (in a large sample of hospitals from southern Spain) are specifically attributable to the disease itself. Hospitalizations for cardiovascular complications and increased costs associated with hospitalization of individuals with diabetes for other unrelated diseases were notable. The optimal management of blood glucose, blood pressure, and lipid concentrations and the early detection and management of existing complications should possibly result in an important reduction of the excess costs associated with hospitalization of individuals with diabetes. For those individuals age Ն45 years, cardiovascular complications were clearly the most important factor determining increased costs from diabetes.
